Precision BioSciences, Inc. (NASDAQ:DTIL – Free Report) – Analysts at HC Wainwright issued their Q1 2027 EPS estimates for shares of Precision BioSciences in a research note issued to investors on Thursday, March 19th. HC Wainwright analyst P. Trucchio anticipates that the company will earn ($0.51) per share for the quarter. The consensus estimate for […]

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX – Free Report) – Analysts at HC Wainwright dropped their FY2026 earnings per share (EPS) estimates for Aldeyra Therapeutics in a research note issued to investors on Wednesday, March 18th. HC Wainwright analyst M. Caufield now expects that the biotechnology company will earn ($0.44) per share for the year, down from […]

Climb Bio, Inc. (NASDAQ:CLYM – Free Report) – Investment analysts at HC Wainwright decreased their Q1 2026 earnings per share estimates for shares of Climb Bio in a report issued on Tuesday, March 10th. HC Wainwright analyst R. Selvaraju now forecasts that the company will post earnings per share of ($0.28) for the quarter, down […]